C hronic periodontitis (CP) is a common inflammatory disease which is characterized by progressive destruction of the tooth supporting structures and ultimately, potential tooth loss. A relationship between CP and diabetes has been recognized for some time. Both diseases share several collective risk factors, however, recent research has provided greater insight into the relationship with evidence emerging for each disease being a co-factor in the pathogenesis of the other. The aim of this review is to examine recent epidemiological evidence for the impact of diabetes on CP, and in the reverse direction, the impact of CP on diabetes. Based on the available evidence to date, it seems likely that the level of metabolic control influences future periodontal disease risk. In the reverse direction, the presence of CP has the potential to adversely affect glycemic control in both diabetes-affected and diabetes-free individuals. CP may potentially be a risk factor for the development of type 2 diabetes in diabetes-free individuals. Interventional studies show that successful treatment of CP may improve metabolic control in people with diabetes in the short term.
relationship between diabetes and CP has been recognized for some time, 5, 6 with the majority of studies focusing on the relationship with type 2 diabetes. The early studies supporting a bi-directional relationship were predominantly cross-sectional in design, precluding the ability to firmly demonstrate direction. 7 However, more recent studies including both prospective cohort and interventional studies have provided further insight into the relationship between these two diseases. 8 The aim of this narrative review is to summarize recent epidemiological evidence of the relationship between CP and diabetes, and report on the recommendations of a recent joint workshop of the European Federation of Periodontology (EFP) and the International Diabetes Federation (IDF). 9 The impact of diabetes on chronic periodontitis
The significance of diabetes as a major risk factor for CP first became apparent in the 1990s in a number of cross-sectional and longitudinal studies investigating the Pima Indian population. The prevalence and incidence of chronic periodontitis was found to be greater in Pima
Indians who had type 2 diabetes compared with those who did not. 10 It is now well accepted that people with diabetes are more likely to have or develop periodontitis, 11 with a threefold higher risk of periodontitis being reported in individuals with diabetes compared to diabetes-free controls. 12 Several explanatory mechanistic pathways ( Figure 2 ) have been proposed. 13, 14 The hyperglycemic state that defines diabetes has several deleterious effects including: the formation of irreversible advanced glycation end-products (AGEs) and the expression of their chief signaling receptor, the receptor for advanced glycation end-products (RAGE); 15, 16 enhanced levels of reactive oxygen species (ROS) and a state of oxidative stress; 17 and modulation of the after adjustment for all known potential confounders. A novel finding of this study was the effect of pre-diabetes on incident CP, 20 however, the significance of this finding is unclear as other studies reported that pre-diabetes (and well controlled diabetes) were not associated with CP. 21 A recent systematic review addressed whether poorly controlled diabetes was associated with CP onset or progression. 22 Thirteen prospective studies comprising 49,262 individuals, including 3,197 with diabetes, met the inclusion criteria. Despite the heterogeneity in the studies a meta-analyses of adjusted estimates showed that diabetes increased the risk of incidence or progression of CP by 86% (RR 1.86, 95% CI 1.3-2.8).
There was considerable variability in the case definitions of CP and in the criteria used to define its progression. Further studies are recommended that also take into account an estimate of the cluster effects of common risk factors to help clarify how shared risk factors interact with blood glucose levels to affect the onset and progression of CP. 22 Summary 
The impact of chronic periodontitis on diabetes
In the reverse direction, CP has the potential to impact the control of diabetes, its associated complications, and also its incidence. From US ENDOCRINOLOGY a mechanistic point of view ( Figure 3 ), the evidence supporting the biological plausibility of an impact of CP on diabetes is limited. 14 The underlying hypothesis relates to inflammation: CP represents a source of chronic inflammation that contributes to the cumulative systemic inflammatory burden. 23, 24 The effects of chronic inflammation have been strongly implicated in the development and control of type 2 diabetes. 25 Potential key mediators between periodontal inflammation and glucose homeostasis include the cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α, the acute phase protein C-reactive protein (CRP) as well as oxygen radicals. All these mediators have been implicated with impaired insulin signaling and resistance. 26 Despite the biological plausibility proposed, the complex etiology of both CP and diabetes makes the impact CP has on diabetes difficult to determine from clinical studies. This is largely due to confounding by shared risk factors including age, obesity, sex and some metabolic biomarkers, for both type 2 diabetes 27 and periodontitis. 28, 29 Epidemiological evidence can broadly be divided into studies assessing the impact of CP on glycemic control (in subjects with or without diabetes), the impact of CP on diabetes complications, and the impact of CP on the development of diabetes (type 2).
A number of studies have found that that in diabetes-free subjects, poorer glycemic control (as defined by increased HbA1c, impaired glucose tolerance, or metabolic syndrome prevalence), is exhibited when CP is present. [30] [31] [32] The impact of CP on insulin resistance, impaired β-cell function, and impaired fasting glucose (IFG) was studied in a cohort (n=19,122) drawn from the from the Korean National Health and Nutrition Examination Survey (KHANES). 33 Subjects A limited number of studies have also assessed the impact of CP on glycemic control in subjects with established diabetes. 34 Two large studies found that CP was significantly associated with poorer glycemic control in subjects with type 2 diabetes. 35, 36 Conversely, two case-control studies did not report a significant difference in HbA1c or fasting blood glucose levels when comparing people with or without periodontitis. 37, 38 A recent review of 14 studies involving 31,988 subjects concluded that CP in patients with diabetes was associated with a higher presence of diabetes-related complications, including retinopathy, nephropathy, neuropathic foot ulceration, various cardiovascular diseases and death. 34 Regarding evidence for the impact of CP on the development (incidence) of type 2 diabetes, a systematic review by Borgnakke et al. identified only four eligible studies. 7, 32, [39] [40] [41] The populations studied included a nationally representative sample in the US, 39 and three Japanese cohorts. 32, 40, 41 Three of the studies reported that severe CP was associated with the development of type 2 diabetes, after adjustment for various confounders. 32, 39, 41 One study found only a tendency for increased risk. 40 A more recent systematic review by Graziani et al.
identified a further two studies, both involving Taiwanese cohorts. 20, 34, 42 One study found that over a 5-year period, adults (aged 35-44 years)
with evidence of CP presented a 33% increased risk of incident hyperglycemia, including diabetes (adjusted HR 1.33, 95% CI 1.09-1.63)
after controlling for potential confounding factors. 20 The other study, a larger retrospective study on 44,601 periodontitis-affected individuals, found that type 2 diabetes incidence was higher in patients undergoing periodontal surgical treatment used as a surrogate for severe CP, than in the controls (adjusted HR 1.19, 95% CI 1.10-1.29). 42 Our own research group, has recently published a prospective longitudinal cohort study aiming to investigate CP as a potential risk factor for incident type 2 diabetes. 43 1,338 men without diabetes, Despite the majority of studies supporting an association between CP and incident diabetes, a recent well-conducted study found no evidence of an association. 44 Data from an 11-year follow-up of the SHIP study were analyzed to evaluate the effects of CP on incident diabetes and long-term HbA1c changes in 2,047 subjects aged 20-81 years. Over a mean follow-up period of 11.1 years, 207 subjects developed diabetes. Baseline measures of CP were not significantly associated with either diabetes incidence or long-term changes in
HbA1c. 44 The conflicting results highlights the need for further studies in different populations. 14 
US ENDOCRINOLOGY

Summary
Most of the studies examining the impact of CP on diabetes are in relation to type 2 diabetes. In individuals with diabetes, the presence of CP is associated with a deterioration in glycemic control and a higher prevalence of diabetes-related complications. In individuals without diabetes, the presence of CP is associated with poorer glycemic control.
CP may potentially be a risk factor for the development of type 2 diabetes in individuals without diabetes.
Interventional studies
The United Kingdom Prospective Diabetes Study (UKPDS) and the
Diabetes Control and Complications trial in the US have demonstrated
that intensive treatment of hyperglycemia can reduce the risk of long-term diabetes complications. [45] [46] [47] A 1% reduction in the HbA1c in the UKPDS was associated with a relative risk reduction of 21% for any diabetes-related endpoint, 21% for diabetes-related deaths, 14% for myocardial infarction and 37% for microvascular complications. 46 Since CP has been associated with poorer glycemic control, an important question is whether periodontal treatment could be an effective therapy to improve glycemic control. This is broadly the order of magnitude expected by adding a second oral antidiabetic medication. 49 Only five studies extend beyond 3 months follow-up. In these studies, periodontal therapy was associated with a 0.02% lowering of HbA1c after 6 months, however, it was not clear whether this was significant, as the 95% CI ranged from 0.20% lower to 0.16% higher.
A recent study investigated the effect of periodontal therapy on in both groups. After 12 months, unadjusted mean HbA1c was 8.3% in the control group and 7.8% in the intensive treatment group; with adjustment for baseline HbA1c, age, sex, ethnicity, smoking status, duration of diabetes, and body mass index, HbA1c was 0.6% (95% CI 0.3-0.9; p<0.0001) lower in the intensive treatment group than in the control group. 50 Despite the majority of clinical trials supporting a hypothesis that successful periodontal treatment improves glycemic control in individuals with type 2 diabetes, a lack of consensus remains. Indeed, a number of studies have found that periodontal treatment has no effect on glycemic control. [51] [52] [53] [54] In 2013,
Engebretson and colleagues reported the results of a large multicenter clinical trial investigating the effects of periodontal treatment on HbA1c levels with 6 months follow-up. 53 514 patients were enrolled across five centers. As the trial progressed, enrollment was stopped early because of futility. At 6 months, mean HbA1c levels in the periodontal treatment group increased 0.17% (SD variability in baseline levels of glycated hemoglobin; and variable follow-up times. 55 Ultimately, this highlights the need for further well-designed studies.
Summary
Evidence from the literature suggests that successful periodontal treatment, which results in the reduction in inflammation from the periodontal tissues, may have the potential to improve the metabolic control of people with diabetes. 56 However, further studies are required to provide more conclusive evidence.
The European Federation of Periodontology and the International Diabetes Federation Workshop 2017
Experts from the fields of gum health and diabetes met for a 'Perio-Diabetes
Workshop' in 2017, the outcomes which have recently been published. 9,14,34,56 The aim was to examine the latest evidence linking periodontal diseases and diabetes. Among the key conclusions reached were:
• there is strong evidence that people with CP have elevated risk for dysglycaemia and insulin resistance;
• there is a moderate level of evidence that certain biological mechanisms mediate the effect of CP on the control of diabetes;
• patients with CP have a higher chance of developing type 2 diabetes; and
• there is evidence that improving periodontal health has benefits in improving metabolic control and/or the complications of diabetes.
A number of management guidelines for physicians, oral health professionals, and patients were proposed. In particular, because of the increased risk for developing periodontitis in patients with diabetes and the negative impact of periodontitis on diabetes control and complications, specific recommendations to physicians were published ( In the case of a negative history, people with diabetes should be advised to check for the above symptoms, and if a positive sign appears, they should visit their dentist
• For all people with newly diagnosed diabetes mellitus, referral for a periodontal examination should occur as part of their ongoing management of diabetes. Even if no periodontitis is diagnosed initially, annual periodontal review is recommended
• For children and adolescents diagnosed with diabetes, annual oral screening is recommended through referral to a dental professional
• Patients with diabetes who have extensive tooth loss should be encouraged to pursue dental rehabilitation to restore adequate mastication for
proper nutrition
• Patients with diabetes should be advised that other oral conditions such as dry mouth and burning mouth may occur, and if so, they should seek advice from their dental practitioner. Also, patients with diabetes are at increased risk of oral fungal infections and experience poorer wound healing than those who do not have diabetes
• The physician should liaise with the dentist over diabetes management prior to the oral intervention and/or surgery to avoid hypoglycemia and to consider its potential impact on the patient's ability to eat
• Oral health education should be provided to all patients with diabetes as part of their overall educational program
• Patients with all forms of diabetes mellitus should be told that periodontal disease risk is increased, and if untreated, the periodontitis has a negative impact on metabolic control and may also increase the risk of complications of their diabetes such as cardiovascular and kidney disease
• Patients should be advised that successful periodontal therapy may have a positive impact upon their metabolic control and diabetes complications • For people with diabetes, physicians should ask about a prior diagnosis of periodontal disease. If a positive diagnosis has been made, the physician should seek to ascertain that periodontal care and maintenance are being provided
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